$2.38 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 66 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 21.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | BIOGEN IDEC INC | $170,171,000 | -3.9% | 514,406 | -8.4% | 7.16% | -4.5% |
| AMGN | Sell | AMGEN INC | $165,350,000 | +16.9% | 1,177,201 | -1.5% | 6.96% | +16.1% |
| GILD | Sell | GILEAD SCIENCES INC | $139,441,000 | +12.2% | 1,309,916 | -12.6% | 5.87% | +11.4% |
| CELG | Buy | CELGENE CORP | $129,353,000 | +20.4% | 1,364,772 | +9.1% | 5.44% | +19.6% |
| BMRN | Buy | BIOMARIN PHARMAC INC | $99,509,000 | +36.9% | 1,379,000 | +18.0% | 4.19% | +36.0% |
| MYL | Buy | MYLAN INC | $98,252,000 | +28.8% | 2,159,851 | +45.9% | 4.14% | +27.9% |
| TEVA | Buy | TEVA PHARMACEUTICALadr | $91,815,000 | +15.8% | 1,708,191 | +12.9% | 3.86% | +15.0% |
| B108PS | Buy | ACTAVIS PLC | $83,929,000 | +10.9% | 347,850 | +2.5% | 3.53% | +10.1% |
| REGN | Sell | REGENERON PHARMCTCLS | $82,126,000 | +27.6% | 227,800 | -0.0% | 3.46% | +26.7% |
| ALXN | Sell | ALEXION PHARM INC | $80,822,000 | +5.8% | 487,408 | -0.3% | 3.40% | +5.0% |
| INCY | Buy | INCYTE CORPORATION | $80,040,000 | -9.8% | 1,631,812 | +3.8% | 3.37% | -10.4% |
| TMO | Buy | THERMO FISHER SCI | $63,844,000 | +22.9% | 524,600 | +19.1% | 2.69% | +22.1% |
| PTCT | Sell | PTC THERAPEUTICS I | $58,199,000 | +43.5% | 1,322,398 | -14.8% | 2.45% | +42.5% |
| PRGO | Buy | PERRIGO CO | $55,205,000 | +7.8% | 367,568 | +4.6% | 2.32% | +7.1% |
| MNKKQ | Buy | MALLINCKRODT PLCshares | $54,132,000 | +40.5% | 600,464 | +24.7% | 2.28% | +39.5% |
| KERX | Sell | KERYX BIOPHARMACEUT | $49,708,000 | -13.6% | 3,615,126 | -3.4% | 2.09% | -14.2% |
| AGN | Buy | ALLERGAN INC | $48,762,000 | +50.0% | 273,650 | +42.5% | 2.05% | +49.0% |
| P103PS | Buy | NPS PHARMACEUTICALS | $44,897,000 | -14.0% | 1,726,824 | +9.3% | 1.89% | -14.6% |
| HALO | Buy | HALOZYME THERAPEUTIC | $41,487,000 | -4.3% | 4,558,982 | +3.9% | 1.75% | -5.0% |
| GEVA | Buy | SYNAGEVA BIOPHARMA | $41,429,000 | -23.5% | 602,345 | +16.6% | 1.74% | -24.0% |
| RDY | Buy | DR REDDYS LABS LTDadr | $38,621,000 | +75.5% | 734,947 | +44.1% | 1.62% | +74.4% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $37,051,000 | -63.7% | 329,897 | -69.4% | 1.56% | -64.0% |
| PTLA | Buy | PORTOLA PHARMACEUTIC | $35,704,000 | -10.4% | 1,412,350 | +3.5% | 1.50% | -11.0% |
| MDVN | Buy | MEDIVATION INC | $33,307,000 | +4121.4% | 336,878 | +3192.1% | 1.40% | +4148.5% |
| OMED | Buy | ONCOMED PHARMACEUT | $32,077,000 | -1.1% | 1,694,517 | +21.7% | 1.35% | -1.8% |
| SGNT | Sell | SAGENT PHARMACEUTI | $32,017,000 | +16.9% | 1,029,472 | -2.8% | 1.35% | +16.0% |
| ABBV | Buy | ABBVIE INC | $25,652,000 | +67.3% | 444,107 | +63.4% | 1.08% | +66.2% |
| PFE | New | PFIZER INC | $24,364,000 | – | 823,949 | +100.0% | 1.02% | – |
| MNTA | Buy | MOMENTA PHARMACEUTIC | $24,205,000 | +19.7% | 2,134,440 | +27.5% | 1.02% | +18.9% |
| IMGN | Sell | IMMUNOGEN INC | $24,035,000 | -37.0% | 2,269,597 | -29.5% | 1.01% | -37.4% |
| UTHR | UNITED THERAPEUTICS | $23,466,000 | +45.4% | 182,400 | 0.0% | 0.99% | +44.4% | |
| CMRX | Buy | CHIMERIX INC | $23,260,000 | +67.8% | 842,149 | +33.3% | 0.98% | +66.8% |
| SGEN | Sell | SEATTLE GENETICS INC | $22,673,000 | -3.2% | 609,819 | -0.4% | 0.95% | -3.8% |
| XLRN | Buy | ACCELERON PHARMA | $21,967,000 | +9.8% | 726,424 | +23.3% | 0.92% | +9.0% |
| INSM | Sell | INSMED INC | $21,210,000 | -46.5% | 1,625,323 | -18.2% | 0.89% | -46.9% |
| AKRXQ | Sell | AKORN INC | $21,205,000 | -16.0% | 584,643 | -23.0% | 0.89% | -16.6% |
| F113PS | Buy | COVIDIEN PLC | $20,101,000 | +2.1% | 232,358 | +6.4% | 0.85% | +1.3% |
| SHPG | Sell | SHIRE PLCsponsored adr | $18,531,000 | -65.9% | 71,536 | -69.0% | 0.78% | -66.1% |
| ICPT | Buy | INTERCEPT PHARMACE | $18,436,000 | +5.3% | 77,893 | +5.3% | 0.78% | +4.6% |
| ISRG | Sell | INTUITIVE SURGIC INC | $17,307,000 | +7.8% | 37,476 | -3.9% | 0.73% | +7.1% |
| KPTI | Buy | KARYOPHARM THERAPE | $17,063,000 | +36.5% | 488,342 | +81.9% | 0.72% | +35.5% |
| THRX | Sell | THERAVANCE INC | $16,602,000 | -68.0% | 971,438 | -44.3% | 0.70% | -68.2% |
| RLYP | Buy | RELYPSA INC | $15,577,000 | -10.2% | 738,573 | +3.6% | 0.66% | -10.7% |
| ALGN | Sell | ALIGN TECH INC | $13,869,000 | -15.9% | 268,360 | -8.8% | 0.58% | -16.5% |
| VRX | Sell | VALEANT PHARMA INTL | $12,516,000 | -41.2% | 95,400 | -43.5% | 0.53% | -41.6% |
| BSX | Buy | BOSTON SCIENTIFIC | $12,367,000 | -7.2% | 1,047,166 | +0.3% | 0.52% | -8.0% |
| NXTM | Buy | NXSTAGE MEDICAL | $11,577,000 | +62.6% | 881,732 | +77.9% | 0.49% | +61.3% |
| TRNX | Sell | TORNIER N V | $11,210,000 | +0.3% | 469,023 | -1.8% | 0.47% | -0.2% |
| DXCM | Sell | DEXCOM INC | $11,048,000 | -3.1% | 276,266 | -3.9% | 0.46% | -3.7% |
| HTWR | Buy | HEARTWARE INTL INC | $10,779,000 | +0.6% | 138,849 | +14.6% | 0.45% | 0.0% |
| CI | Buy | CIGNA CORP | $9,356,000 | +19.9% | 103,164 | +21.6% | 0.39% | +19.0% |
| AMPH | New | AMPHASTAR PHARMACTLS | $7,692,000 | – | 660,232 | +100.0% | 0.32% | – |
| NVO | Buy | NOVO-NORDISK ASadr | $7,009,000 | +17.2% | 147,185 | +13.6% | 0.30% | +16.6% |
| INGN | Sell | INOGEN INC | $5,185,000 | -18.3% | 251,600 | -10.5% | 0.22% | -19.0% |
| CBAY | New | CYMABAY THERAPEUTICS | $4,847,000 | – | 708,585 | +100.0% | 0.20% | – |
| NVS | Buy | NOVARTIS AGsponsored adr | $3,916,000 | +24.7% | 41,600 | +19.9% | 0.16% | +24.1% |
| AMBI | New | AMBIT BIOSCIENCES | $2,250,000 | – | 146,111 | +100.0% | 0.10% | – |
| IMDZ | New | IMMUNE DESIGN CORP | $1,678,000 | – | 95,000 | +100.0% | 0.07% | – |
| TNDM | Buy | TANDEM DIABETES CA | $1,361,000 | +51.6% | 101,422 | +83.6% | 0.06% | +50.0% |
| EBIO | New | ELEVEN BIOTHERAPEU | $1,253,000 | – | 112,485 | +100.0% | 0.05% | – |
| PRQR | New | PROQR THRAPEUTICS | $1,203,000 | – | 70,000 | +100.0% | 0.05% | – |
| FOLD | New | AMICUS THERAPEUTICS | $1,190,000 | – | 200,000 | +100.0% | 0.05% | – |
| ALDR | Buy | ALDER BIOPHARMACEU | $1,132,000 | +39.2% | 89,300 | +120.4% | 0.05% | +41.2% |
| RNA | Buy | PROSENSA HLDGS | $794,000 | -17.0% | 94,184 | +24.2% | 0.03% | -19.5% |
| WX | Buy | WUXI PHAR ADS | $661,000 | +52.3% | 18,873 | +43.1% | 0.03% | +55.6% |
| ANTH | Buy | ANTHERA PHARMACEUT | $476,000 | -36.0% | 247,961 | +12.9% | 0.02% | -37.5% |
| ARAY | Exit | ACCURAY INC | $0 | – | -491,505 | -100.0% | -0.18% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA | $0 | – | -152,151 | -100.0% | -0.21% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -360,724 | -100.0% | -0.23% | – |
| CLVS | Exit | CLOVIS ONCOLOGY | $0 | – | -314,952 | -100.0% | -0.55% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -654,582 | -100.0% | -1.60% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -246,789 | -100.0% | -1.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.